Your browser doesn't support javascript.
loading
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.
Subbiah, Vivek; Sahai, Vaibhav; Maglic, Dejan; Bruderek, Kamil; Touré, B Barry; Zhao, Songping; Valverde, Roberto; O'Hearn, Patrick J; Moustakas, Demetri T; Schönherr, Heike; Gerami-Moayed, Nastaran; Taylor, Alexander M; Hudson, Brandi M; Houde, Damian J; Pal, Debjani; Foster, Lindsey; Gunaydin, Hakan; Ayaz, Pelin; Sharon, Dina A; Goyal, Lipika; Schram, Alison M; Kamath, Suneel; Sherwin, Cori Ann; Schmidt-Kittler, Oleg; Jen, Kai Yu; Ricard, Fabien; Wolf, Beni B; Shaw, David E; Bergstrom, Donald A; Watters, James; Casaletto, Jessica B.
Afiliação
  • Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sahai V; University of Michigan, Ann Arbor, Michigan.
  • Maglic D; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Bruderek K; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Touré BB; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Zhao S; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Valverde R; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • O'Hearn PJ; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Moustakas DT; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Schönherr H; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Gerami-Moayed N; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Taylor AM; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Hudson BM; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Houde DJ; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Pal D; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Foster L; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Gunaydin H; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Ayaz P; D. E. Shaw Research, New York, New York.
  • Sharon DA; D. E. Shaw Research, New York, New York.
  • Goyal L; Massachusetts General Hospital, Boston, Massachusetts.
  • Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kamath S; The Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Sherwin CA; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Schmidt-Kittler O; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Jen KY; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Ricard F; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Wolf BB; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Shaw DE; D. E. Shaw Research, New York, New York.
  • Bergstrom DA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York.
  • Watters J; Relay Therapeutics, Inc., Cambridge, Massachusetts.
  • Casaletto JB; Relay Therapeutics, Inc., Cambridge, Massachusetts.
Cancer Discov ; 13(9): 2012-2031, 2023 09 06.
Article em En | MEDLINE | ID: mdl-37270847
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article